INO 5042

Drug Profile

INO 5042

Latest Information Update: 28 Aug 2002

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Innothera
  • Class Cardiotonics; Small molecules; Vascular disorder therapies
  • Mechanism of Action Dinoprostone receptor antagonists; Prostaglandin synthase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Venous insufficiency

Most Recent Events

  • 05 Mar 1999 Two preclinical studies have been added to the Vascular Disorders pharmacodynamics section ,
  • 03 Jun 1998 New profile
  • 03 Jun 1998 Phase-I clinical trials for Venous insufficiency in France (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top